The finalized international pricing model covers too few drugs to meaningfully reduce Medicare spending

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Drug pricing policy, insurance prior authorization, and essential drug shortages affecting medication affordability and access.

The economics of healthcare, including insurance, spending, and affordability.